Patients with particular MHC class I and Class II haplotypes, female gender, and other risk factors, that predispose an individual to the development of autoimmune disease, are particularly susceptible to the development of IFN-induced SLE or CLE. This evidence concerns the gene IFNA1 and systemic lupus erythematosus.